ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Texas » Neurology

Top Neurology Prescribers in Texas

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
PATIENCE READING MD

Neurology

1,103

$319K

125
92 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 28%

$289
Average prescription price

Avg: $218

SEVAK OHANIAN MD

Neurology

4,424

$935K

453
414 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

2%
patients receiving schedule three controlled substances

Avg: 5%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

52%
prescriptions for brand name drugs

Avg: 28%

$211
Average prescription price

Avg: $218

MARTIN SOLOMON MD

Neurology

1,972

$448K

243
179 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

5%
patients receiving schedule three controlled substances

Avg: 5%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 28%

$227
Average prescription price

Avg: $218

STEVEN HERZOG M.D.

Neurology

615

$48.6K

153
81 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

22%
patients receiving schedule three controlled substances

Avg: 5%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 28%

$79
Average prescription price

Avg: $218

MASSOUD BINA M.D.,P.A.

Neurology

497

$56.1K

87
72 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 28%

$113
Average prescription price

Avg: $218

WILLIAM TOBLEMAN MD

Neurology

1,929

$185K

126
80 are 65+

33%
patients receiving schedule two controlled substances

Avg: 2%

36%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 28%

$96
Average prescription price

Avg: $218

STEPHANIE SCHWARTZ MD

Neurology

1,270

$285K

174
123 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

43%
prescriptions for brand name drugs

Avg: 28%

$225
Average prescription price

Avg: $218

JEROME LOPEZ MD

Neurology

2,006

$227K

264
124 are 65+

24%
patients receiving schedule two controlled substances

Avg: 2%

14%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 28%

$113
Average prescription price

Avg: $218

ELMYRA ENCARNACION MD

Neurology

2,248

$369K

344
283 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

15%
prescriptions for brand name drugs

Avg: 28%

$164
Average prescription price

Avg: $218

LILLY CHEN M.D.

Neurology

2,260

$201K

158
41 are 65+

35%
patients receiving schedule two controlled substances

Avg: 2%

80%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 28%

$89
Average prescription price

Avg: $218

THOMAS LEAVENS M.D.

Neurology

2,112

$601K

352
278 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 28%

$284
Average prescription price

Avg: $218

RICHARD SAWYERS

Neurology

619

$74.7K

65
53 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 28%

$121
Average prescription price

Avg: $218

KRISHNABABU CHUNDURI MD

Neurology

2,069

$424K

281
197 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

7%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 28%

$205
Average prescription price

Avg: $218

HECTOR COLON M.D.

Neurology

1,776

$716K

160
93 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 28%

$403
Average prescription price

Avg: $218

RICHARD HAMER MD

Neurology

10,787

$1.92M

962
682 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

6%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 28%

$178
Average prescription price

Avg: $218

HERBERT EDMUNDSON M.D., PHD

Neurology

1,709

$287K

216
175 are 65+

9%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

42%
prescriptions for brand name drugs

Avg: 28%

$168
Average prescription price

Avg: $218

GEORGE KARIAMPUZHA MD

Neurology

3,563

$718K

361
224 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

4%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

39%
prescriptions for brand name drugs

Avg: 28%

$202
Average prescription price

Avg: $218

ANITA GOTTIPATI MD

Neurology

1,131

$80.9K

149
80 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

11%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 28%

$71
Average prescription price

Avg: $218

NORMA MELAMED

Neurology

2,111

$308K

212
186 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

36%
prescriptions for brand name drugs

Avg: 28%

$146
Average prescription price

Avg: $218

CHARLECE HUGHES D.O.

Neurology

3,045

$709K

322
234 are 65+

4%
patients receiving schedule two controlled substances

Avg: 2%

5%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 28%

$233
Average prescription price

Avg: $218

MIKE YUAN MD, PHD

Neurology

1,875

$284K

231
160 are 65+

7%
patients receiving schedule two controlled substances

Avg: 2%

20%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 28%

$152
Average prescription price

Avg: $218

DEBORAH COMBS CANTRELL MD

Neurology

2,159

$954K

228
123 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

53%
prescriptions for brand name drugs

Avg: 28%

$442
Average prescription price

Avg: $218

HUSAM ALKHERSAM M.D.

Neurology

1,525

$251K

221
157 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

10%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 28%

$165
Average prescription price

Avg: $218

SHERI HULL DO

Neurology

1,179

$271K

150
112 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 28%

$230
Average prescription price

Avg: $218

CHEOR KIM M.D.

Neurology

2,460

$109K

127
62 are 65+

11%
patients receiving schedule two controlled substances

Avg: 2%

54%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 28%

$44
Average prescription price

Avg: $218

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank